Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel alkylammonium acetate method for AcHMF. High yield, base-free process. Reliable supply chain for pharmaceutical intermediates and biomass-derived platform compounds.
Patent CN110564755B details a novel enzymatic route for (S)-3-phenyl-1,2-epoxypropane. Discover cost-effective, metal-free manufacturing solutions for high-purity API precursors.
Patent CN117625571A reveals high-tolerance ketoreductase for ezetimibe intermediate. Enhances purity and reduces manufacturing costs for pharmaceutical supply chains.
Patent CN110627769A reveals mild nicotine synthesis. Offers cost reduction and high purity for electronic chemical manufacturing and pharmaceutical intermediates.
Patent CN115109760A discloses engineered monoamine oxidase for Boceprevir and Nirmatrelvir intermediates, offering superior catalytic efficiency and cost-effective manufacturing solutions.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Novel enzymatic route reduces cost and environmental impact for high-purity pharmaceutical intermediate manufacturing supply chains ensuring reliable global sourcing and scalable production capabilities for advanced antifungal drug development projects.
Novel catalyst-free metal process for high-purity LiFSI production. Reduces contamination risks and simplifies supply chain for battery manufacturers globally seeking reliable partners.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104788415B details asymmetric synthesis of chiral dihydrocoumarin derivatives. Offers high stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110183394B reveals a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering safer cyanation and scalable manufacturing for global supply chains.
Patent CN103857656A details enantioselective pyrrolidine synthesis. This report analyzes technical breakthroughs and supply chain cost advantages for global agrochemical manufacturers.
Patent CN110183394B details a mild photocatalytic route for 3-nitrile ethyl-2-hydrocarbyl-4H-benzoxazine, offering cost-effective API intermediate manufacturing.
Patent CN110183394B reveals a blue-light mediated synthesis of benzoxazine derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111471020B reveals a novel Rh-catalyzed route for Avapritinib intermediates, offering safer conditions and reduced costs for reliable API manufacturing.
Patent CN120624386B reveals a high-pH stable alcohol dehydrogenase mutant for natural raspberry ketone. Enables cost reduction and scalable supply for flavor industries.
Patent CN115057794B enables visible light-induced demethylation. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Novel NHC catalyzed visible light synthesis method offers green efficient production for pharmaceutical intermediates supply chain.
Patent CN104311407B reveals ionic liquid catalysis for high-purity β-IP. Offers cost reduction and supply reliability for vitamin E intermediates.